Study Title

Exploratory, Single-institution Study, Comparing 68Ga-RM2 PET/CT Versus 68Ga-PSMA-617 PET/CT in Patients Diagnosed With Intermediate Risk Prostate Cancer Candidates for Radical Prostatectomy

Study Details

Description:

Patients with primary intermediate risk prostate cancer for whom radical prostatectomy is indicated, will be invited to participate to the present study. Positron Emission Tomography coupled with scanner (PET-CT) using a radiotracer : 68Ga-RM2 and Positron Emission Tomography coupled with scanner (PET-CT) using another radiotracer : 68Ga-PSMA-617, will be scheduled.

Sponsor:

University Hospital, Bordeaux

Contacts:

Henri CLERMONT-GALLERANDE (Principal Investigator)

henri.de-clermont-galleran@chu-bordeaux.fr

05 56 79 55 40

Clément MORGAT

clement.morgat@chu-bordeaux.fr

05 56 79 55 40

© 2021 XCancer Software LLC

Contact XCancer: 402-991-8468